Abstract: New polymorphic crystal forms of the following compound are disclosed: (I). This compound is used to make florbetapir (18F).
| # | Name | Date |
|---|---|---|
| 1 | 202517046322-STATEMENT OF UNDERTAKING (FORM 3) [14-05-2025(online)].pdf | 2025-05-14 |
| 2 | 202517046322-REQUEST FOR EXAMINATION (FORM-18) [14-05-2025(online)].pdf | 2025-05-14 |
| 3 | 202517046322-POWER OF AUTHORITY [14-05-2025(online)].pdf | 2025-05-14 |
| 4 | 202517046322-FORM 18 [14-05-2025(online)].pdf | 2025-05-14 |
| 5 | 202517046322-FORM 1 [14-05-2025(online)].pdf | 2025-05-14 |
| 6 | 202517046322-DRAWINGS [14-05-2025(online)].pdf | 2025-05-14 |
| 7 | 202517046322-DECLARATION OF INVENTORSHIP (FORM 5) [14-05-2025(online)].pdf | 2025-05-14 |
| 8 | 202517046322-COMPLETE SPECIFICATION [14-05-2025(online)].pdf | 2025-05-14 |
| 9 | 202517046322-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-05-2025(online)].pdf | 2025-05-14 |
| 10 | 202517046322-MARKED COPIES OF AMENDEMENTS [28-05-2025(online)].pdf | 2025-05-28 |
| 11 | 202517046322-FORM 13 [28-05-2025(online)].pdf | 2025-05-28 |
| 12 | 202517046322-AMMENDED DOCUMENTS [28-05-2025(online)].pdf | 2025-05-28 |
| 13 | 202517046322-FORM 3 [06-06-2025(online)].pdf | 2025-06-06 |